Caffeine prevents experimental liver fibrosis by blocking the expression of TGF-β

Jonathan Arauz, Natanael Zarco, José Segovia, Mineko Shibayama, Vı́ctor Tsutsumi, Pablo Muriel

European Journal of Gastroenterology & Hepatology · 2013 · 70 citations · 33 references

Abstract

Our results show that caffeine prevents experimental cirrhosis; the mechanisms of action are associated with its antioxidant properties and mainly by its ability to block the elevation of the profibrogenic cytokine transforming growth factor-β, which may be associated with attenuation of the inflammatory and fibrotic processes.

References

33